1. Home
  2. CHMI vs PYPD Comparison

CHMI vs PYPD Comparison

Compare CHMI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.59

Market Cap

83.3M

Sector

Real Estate

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.42

Market Cap

73.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
PYPD
Founded
2012
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
73.0M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CHMI
PYPD
Price
$2.59
$4.42
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$2.75
$12.00
AVG Volume (30 Days)
226.8K
76.9K
Earning Date
11-06-2025
02-11-2026
Dividend Yield
15.87%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$40,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$31.73
N/A
P/E Ratio
$134.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$2.30
52 Week High
$3.68
$4.63

Technical Indicators

Market Signals
Indicator
CHMI
PYPD
Relative Strength Index (RSI) 52.90 73.55
Support Level $2.47 $4.10
Resistance Level $2.78 $4.63
Average True Range (ATR) 0.08 0.17
MACD -0.02 0.04
Stochastic Oscillator 40.32 75.00

Price Performance

Historical Comparison
CHMI
PYPD

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: